Akram Al-Mahdawi

The Comparative Effectiveness of Rituximab and Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Real-World Study

Bassem Yamout, Raed Al-Roughani, Samar Farouk Ahmed, Akram Al-Mahdawi et autres

Epidemiology, Clinical Characteristics, and Treatment patterns in a Large Pediatric-Onset Multiple Sclerosis Cohort

Maya Zeineddine, Ghida Ismail, Raed Al-Roughani, Samar Farouk Ahmed et autres

Evaluating the Usefulness of 24-Hour Video EEG Monitoring in Dr. Sa’ad Alwitry’s Hospital, Baghdad, Iraq

Ebtehal Dhiyaa, Akram Al-Mahdawi, Muataz Fairooz Abd

Background: Video electroencephalography (VEEG) monitoring, which combines EEG with synchronized video recording, is a valuable but resource-intensive tool for evaluating seizure disorders. While its role in diagnosis and classification is established, its specific impact on altering provisional diagnoses and guiding treatment remains …

iq (code pays fourni par la source)

Clinically relevant MRI findings in headache patients: diagnostic yield and resource utilization in a referral-based cohort

Farah Akram Al Mahdawi, Akram Al-Mahdawi, Maryam Issa Al-Ani, Mohammed Tareq Mutar

Abstract Background Headache disorders affect over half of the global population, with a prevalence of 52% for all headaches, 14% for migraine, and 26% for tension-type headache. In 2023, an estimated 2.9 billion people (34.6% globally) were affected by headache disorders, with …

iq (code pays fourni par la source)

The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients

Ghida Ismail, Maya M Zeineddine, Raed Al-Roughani, Samar Farouk Ahmed et autres

Rituximab (RTX) is increasingly used off-label for the treatment of multiple sclerosis (MS), yet real-world evidence from Middle Eastern populations remains limited. This multicenter, retrospective observational study evaluated the effectiveness and safety of RTX using data from the MENACTRIMS registry across seven …

fr, lb, kw, iq, ae, om, Tunisie, sa, jo (code pays fourni par la source)

Assessment of autonomic nervous system functions in patients with chronic inflammatory demyelinating polyradiculoneuropathy: an electrodiagnostic study

Raghda Nidal Hathal, Farqad Bader Hamdan, Akram Al-Mahdawi

Background and objectives: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic immune-mediated neuropathy predominantly affecting the peripheral nervous system including the nerve roots. The objectives of this study were to assess autonomic dysfunction in patients with CIDP using electrodiagnostic techniques and to …

iq (code pays fourni par la source)

Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study

Bassem Yamout, Raed Alroughani, Akram Al-Mahdawi, Samia Joseph Khoury et autres

BACKGROUND: Head-to-head randomised trials or real-world studies comparing the safety and efficacy of natalizumab and anti-CD20 monoclonal antibodies are limited. This study aimed to compare the effectiveness and safety of natalizumab versus ocrelizumab/rituximab in a real-world cohort of relapsing-remitting multiple sclerosis (RRMS) …

us, kw, iq, lb, ae, om, Tunisie, sa, jo, cy, fr (code pays fourni par la source)

Language deficit in non-dominant hemisphere stroke patients

Huda Almashhadani, Akram Al-Mahdawi

Background: Despite the long history of research favoring the left hemisphere is dominant for language processing in most right-handed subjects. There is accumulating evidence that the right hemisphere contributes to language.Aim: evaluate language deficits in right hemisphere stroke survivors so they will …

51. The Comparative Effectiveness of Natalizumab and Anti-CD20 Monoclonal Antibodies in Relapsing-Remitting Multiple Sclerosis: A Real-World based Study

Maya M Zeineddine, Raed Alroughani, Samar Farouk Ahmed, Akram Al-Mahdawi et autres

fr, lb, kw, iq, ae, om, Tunisie, sa, jo, cy (code pays fourni par la source)

181. The Real-world Efficacy and Safety of Off-label Rituximab in a Large Cohort of Middle Eastern Multiple Sclerosis Patients

Ghida Ismail, Maya M Zeineddine, Raed Alroughani, Samar Farouk Ahmed et autres

fr, lb, kw, iq, ae, om, Tunisie, sa, jo, cy (code pays fourni par la source)

164. Prospective Multi Centered Study on the Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis Patients

Akram Al-Mahdawi, Anmar Oday Hatem, Ismael Raje Aayd

iq (code pays fourni par la source)

Safety and effectiveness of disease-modifying therapies after switching from natalizumab

Maya M Zeineddine, Raed Alroughani, Samar Farouk Ahmed, Samia Joseph Khoury et autres

Introduction: One strategy to mitigate progressive multifocal leukoencephalopathy (PML) risk is to switch to other highly effective disease-modifying therapies (DMTs). However, the optimal switch DMT following natalizumab (NTZ) discontinuation is yet to be determined. Objective: The objective of the study is to …

fr, lb, kw, iq, om, Algérie, ae, Tunisie, Égypte, us, cy (code pays fourni par la source)